Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses.

× No keyword cloud information.

36 in total

1. Recombinant vaccinia viruses. Design, generation, and isolation.

Authors: C C Broder; P L Earl
Journal: Mol Biotechnol Date: 1999-12-15 Impact factor: 2.695

2. Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression.

Authors: Susan Parrish; Bernard Moss
Journal: J Virol Date: 2006-01 Impact factor: 5.103

3. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

Authors: Zhongde Wang; Corinna La Rosa; Zhongqi Li; Heang Ly; Aparna Krishnan; Joy Martinez; William J Britt; Don J Diamond
Journal: Vaccine Date: 2006-10-06 Impact factor: 3.641

4. Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.

Authors: Patricia L Earl; Jeffrey L Americo; Bernard Moss
Journal: J Virol Date: 2003-10 Impact factor: 5.103

5. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.

Authors: R L Roper; E J Wolffe; A Weisberg; B Moss
Journal: J Virol Date: 1998-05 Impact factor: 5.103

6. Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

Authors: R Vemulapalli; S Cravero; C L Calvert; T E Toth; N Sriranganathan; S M Boyle; O L Rossetti; G G Schurig
Journal: Clin Diagn Lab Immunol Date: 2000-01

7. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.

Authors: Y Xiang; B Moss
Journal: Proc Natl Acad Sci U S A Date: 1999-09-28 Impact factor: 11.205

8. DNA packaging mutant: repression of the vaccinia virus A32 gene results in noninfectious, DNA-deficient, spherical, enveloped particles.

Authors: M C Cassetti; M Merchlinsky; E J Wolffe; A S Weisberg; B Moss
Journal: J Virol Date: 1998-07 Impact factor: 5.103

9. Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.

Authors: A Seth; I Ourmanov; M J Kuroda; J E Schmitz; M W Carroll; L S Wyatt; B Moss; M A Forman; V M Hirsch; N L Letvin
Journal: Proc Natl Acad Sci U S A Date: 1998-08-18 Impact factor: 11.205

10. Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors: Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal: J Virol Date: 2008-02-20 Impact factor: 5.103